PharmExec Direct: Having trouble viewing the email? Click Here

In this ISSUE

The Role of Commercial Partners in Sales Strategy Development

Q&A: Esperion CFO, Rick Bartram

Planning Ahead with AstraZeneca's Pam Cheng

Advertisement
Top Story
FDA Pushes for "Clear Global Policy Strategy"
FDA is examining and updating its programs for overseeing global operations and international affairs
/Read more/
Advertisement
Deloitte's 2019 Life Sciences accounting and financial reporting update
Insights on new accounting standards and more
A year of major change for life sciences companies is underway. Deloitte's latest update on life sciences financial reporting explains what accounting departments need to know to keep up in a rapidly evolving environment.
Download the full report here
ADVERTISEMENT

Advertisement
C-Suite
Time for a Chief Adherence Officer?
The best way to capitalize on the potential revenue influx from enterprise-level drug adherence programs is to create room at the executive table for a Chief Adherence Officer, writes Tom Kottler
/Read more/
Advertisement
AI-powered Biomedical Literature Discovery supporting Science-based Business Decisions
Tuesday, May 21, 2019 at 11am EDT | 8am PDT | 4pm BST | 5pm CEST
Register Now
C-Suite
Survey Spotlights the CFO's Strategic Rise
Findings support the belief that today's pharma finance teams should be engaged across all functional areas, including regulatory, supply chain, manufacturing, and commercial. What does that mean for current and future CFOs in the industry?
/Read more/
 
Technology
Adopting New Technology: Barriers and Breakthroughs
Chrissy Bell discusses preserving positive ROI amid healthcare's innovation explosion
/Read More/
 
Audio
The Pharm Exec Podcast: Ruling in Favor of Biotech
Pharm Exec Editor-in-Chief Lisa Henderson speaks with Bill Newell, CEO of Sutro Biopharma, about his background in corporate law and how informs his role as a biotech executive and the importance of collaboration between big pharma and biotech
/Click here to listen/

Calendar
/ May 15: MDR Workshop: Transitioning to the EU MDR and Managing Legacy Devices /
Brussels, Belgium
/ May 20–22: 21st Medicaid and Government Pricing Congress /
Orlando, FL
/ May 30–31: Pharmaceutical Research &Innovations in Pharma Industry /
Orlando, FL
/ June 3–6: BIO International Convention /
Philadelphia, PA
/ June 12–13: Rare Disease Innovation and Partnering Summit /
Boston, MA
/ June 14–15: 13th World Drug Delivery Summit /
Montreal, Canada
/ June 23–27: DIA 2019 /
San Diego, CA
/ November 13–14: 6th Annual Global Compliance Congress /
London, UK
/ eyeforpharma Awards 2019 /
Philadelphia, PA

Industry update
//Sarepta Therapeutics (Cambridge, MA) appointed Mary Ann Gray, Ph.D., to its Board of Directors. // Akorn (Lake Forest, IL) named Dandy Dorado-Boladeres as Executive Vice President of Global Quality. // Agenus (Lexington, MA) appointed Dr. Manuel Hidalgo, MD, PhD, as Strategic Advisor and Paulo Moreira as Global Head of Clinical Operations. // Kivett & Company public relations veteran Tom Kivett announced the launcg of Brightfluence (New York, NY) to provide integrated communications services to startups and small to mid-size firms in health tech.
advertise with us / print subscribe / digital subscribe / visit pharmexec.com